Search

Your search keyword '"Hogarty, Michael D"' showing total 62 results
Start Over Author "Hogarty, Michael D" Publisher american association for cancer research (aacr)
62 results on '"Hogarty, Michael D"'

1. Supplementary fig 3 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

2. Data from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure S1 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

4. Supplementary fig 3 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

5. Supplementary fig 2 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

6. Data from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

7. Supplementary fig 2 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure S1 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, primary, Ding, Xiangming, primary, Zhang, Fan F., primary, Hibbitts, Emily, primary, Kennedy, Rebekah, primary, Tibbetts, Rachelle, primary, Wong-Michalak, Shannon, primary, Craig, David W., primary, Manojlovic, Zarko, primary, Hogarty, Michael D., primary, Kreissman, Susan, primary, Bagatell, Rochelle, primary, Irwin, Meredith S., primary, Park, Julie R., primary, and Asgharzadeh, Shahab, primary

Published
2023
Full Text
View/download PDF

9. SUPPLEMENTAL MATERIALS from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Data (for publication) from Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

Author

Evageliou, Nicholas F., primary, Haber, Michelle, primary, Vu, Annette, primary, Laetsch, Theodore W., primary, Murray, Jayne, primary, Gamble, Laura D., primary, Cheng, Ngan Ching, primary, Liu, Kangning, primary, Reese, Megan, primary, Corrigan, Kelly A., primary, Ziegler, David S., primary, Webber, Hannah, primary, Hayes, Candice S., primary, Pawel, Bruce, primary, Marshall, Glenn M., primary, Zhao, Huaqing, primary, Gilmour, Susan K., primary, Norris, Murray D., primary, and Hogarty, Michael D., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 1, Tables 1-3 from miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

Author

De Preter, Katleen, primary, Mestdagh, Pieter, primary, Vermeulen, Joëlle, primary, Zeka, Fjoralba, primary, Naranjo, Arlene, primary, Bray, Isabella, primary, Castel, Victoria, primary, Chen, Caifu, primary, Drozynska, Elzbieta, primary, Eggert, Angelika, primary, Hogarty, Michael D., primary, Iżycka-Swieszewska, Ewa, primary, London, Wendy B., primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bryan, Kenneth, primary, Schowe, Benjamin, primary, van Sluis, Peter, primary, Molenaar, Jan J., primary, Schramm, Alexander, primary, Schulte, Johannes H., primary, Stallings, Raymond L., primary, Versteeg, Rogier, primary, Laureys, Geneviève, primary, Van Roy, Nadine, primary, Speleman, Frank, primary, and Vandesompele, Jo, primary

Published
2023
Full Text
View/download PDF

12. Table S3 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

13. Table S1 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

14. Table S1 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 1, Tables 1-3 from miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

Author

De Preter, Katleen, primary, Mestdagh, Pieter, primary, Vermeulen, Joëlle, primary, Zeka, Fjoralba, primary, Naranjo, Arlene, primary, Bray, Isabella, primary, Castel, Victoria, primary, Chen, Caifu, primary, Drozynska, Elzbieta, primary, Eggert, Angelika, primary, Hogarty, Michael D., primary, Iżycka-Swieszewska, Ewa, primary, London, Wendy B., primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bryan, Kenneth, primary, Schowe, Benjamin, primary, van Sluis, Peter, primary, Molenaar, Jan J., primary, Schramm, Alexander, primary, Schulte, Johannes H., primary, Stallings, Raymond L., primary, Versteeg, Rogier, primary, Laureys, Geneviève, primary, Van Roy, Nadine, primary, Speleman, Frank, primary, and Vandesompele, Jo, primary

Published
2023
Full Text
View/download PDF

16. Table S4 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

17. Table S2 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

18. Table S4 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

19. Table S4 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

20. Table S3 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Data (for publication) from Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

Author

Evageliou, Nicholas F., primary, Haber, Michelle, primary, Vu, Annette, primary, Laetsch, Theodore W., primary, Murray, Jayne, primary, Gamble, Laura D., primary, Cheng, Ngan Ching, primary, Liu, Kangning, primary, Reese, Megan, primary, Corrigan, Kelly A., primary, Ziegler, David S., primary, Webber, Hannah, primary, Hayes, Candice S., primary, Pawel, Bruce, primary, Marshall, Glenn M., primary, Zhao, Huaqing, primary, Gilmour, Susan K., primary, Norris, Murray D., primary, and Hogarty, Michael D., primary

Published
2023
Full Text
View/download PDF

22. Table S2 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

23. Table S4 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, primary, Carmichael, Lakeesha, primary, Kim, KyungMann, primary, Mendonça, Eneida A., primary, Song, Yiqiang, primary, Hess, Dustin, primary, Reville, Patrick K., primary, London, Wendy B., primary, Naranjo, Arlene, primary, Hank, Jacquelyn A., primary, Diccianni, Mitchell B., primary, Reisfeld, Ralph A., primary, Gillies, Stephen D., primary, Matthay, Katherine K., primary, Cohn, Susan L., primary, Hogarty, Michael D., primary, Maris, John M., primary, Park, Julie R., primary, Ozkaynak, M. Fevzi, primary, Gilman, Andrew L., primary, Yu, Alice L., primary, and Sondel, Paul M., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure Legends 1-3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 1 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

28. Data from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

33. Data from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 2 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 2 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure Legends 1-3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Author

Hogarty, Michael D., primary, Norris, Murray D., primary, Davis, Kimberly, primary, Liu, Xueyuan, primary, Evageliou, Nicholas F., primary, Hayes, Candace S., primary, Pawel, Bruce, primary, Guo, Rong, primary, Zhao, Huaqing, primary, Sekyere, Eric, primary, Keating, Joanna, primary, Thomas, Wayne, primary, Cheng, Ngan Ching, primary, Murray, Jayne, primary, Smith, Janice, primary, Sutton, Rosemary, primary, Venn, Nicola, primary, London, Wendy B., primary, Buxton, Allen, primary, Gilmour, Susan K., primary, Marshall, Glenn M., primary, and Haber, Michelle, primary

Published
2023
Full Text
View/download PDF

44. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Author

Pinto, Navin, primary, Naranjo, Arlene, additional, Ding, Xiangming, additional, Zhang, Fan F., additional, Hibbitts, Emily, additional, Kennedy, Rebekah, additional, Tibbetts, Rachelle, additional, Wong-Michalak, Shannon, additional, Craig, David W., additional, Manojlovic, Zarko, additional, Hogarty, Michael D., additional, Kreissman, Susan, additional, Bagatell, Rochelle, additional, Irwin, Meredith S., additional, Park, Julie R., additional, and Asgharzadeh, Shahab, additional

Published
2023
Full Text
View/download PDF

45. Abstract PR11: Synthetic lethality between ATRX mutations and MYCN amplification in neuroblastoma

Author

Zeineldin, Maged, primary, Federico, Sara M., additional, Griffith, Lyra, additional, Jeon, Jongyre, additional, Chen, Xiang, additional, Easton, John, additional, Wu, Jianrong, additional, Mao, Shenghua, additional, Liu, Yanling, additional, Naranjo, Arlene, additional, Pappo, Alberto S., additional, Hogarty, Michael D., additional, and Dyer, Michael A., additional

Published
2018
Full Text
View/download PDF

46. Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Author

Erbe, Amy K., primary, Wang, Wei, additional, Carmichael, Lakeesha, additional, Kim, KyungMann, additional, Mendonça, Eneida A., additional, Song, Yiqiang, additional, Hess, Dustin, additional, Reville, Patrick K., additional, London, Wendy B., additional, Naranjo, Arlene, additional, Hank, Jacquelyn A., additional, Diccianni, Mitchell B., additional, Reisfeld, Ralph A., additional, Gillies, Stephen D., additional, Matthay, Katherine K., additional, Cohn, Susan L., additional, Hogarty, Michael D., additional, Maris, John M., additional, Park, Julie R., additional, Ozkaynak, M. Fevzi, additional, Gilman, Andrew L., additional, Yu, Alice L., additional, and Sondel, Paul M., additional

Published
2018
Full Text
View/download PDF

49. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

Author

Evageliou, Nicholas F., primary, Haber, Michelle, additional, Vu, Annette, additional, Laetsch, Theodore W., additional, Murray, Jayne, additional, Gamble, Laura D., additional, Cheng, Ngan Ching, additional, Liu, Kangning, additional, Reese, Megan, additional, Corrigan, Kelly A., additional, Ziegler, David S., additional, Webber, Hannah, additional, Hayes, Candice S., additional, Pawel, Bruce, additional, Marshall, Glenn M., additional, Zhao, Huaqing, additional, Gilmour, Susan K., additional, Norris, Murray D., additional, and Hogarty, Michael D., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results